Reviva Pharmaceuticals RVPH reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Reviva Pharmaceuticals missed estimated earnings by 42.86%, reporting an EPS of $-0.4 versus an estimate of $-0.28.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 4.65% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Reviva Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.